Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

The originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as ‘n’ and ‘u’, respectively. These errors have now been corrected in both the PDF and HTML versions of the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S Chard, Nicholas R Lemoine, Yaohe Wang
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/480ad26356494b4ba55bf572179933af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:480ad26356494b4ba55bf572179933af
record_format	dspace
spelling	oai:doaj.org-article:480ad26356494b4ba55bf572179933af2021-12-02T17:32:01ZAuthor Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent10.1038/s41467-017-02205-92041-1723https://doaj.org/article/480ad26356494b4ba55bf572179933af2018-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02205-9https://doaj.org/toc/2041-1723The originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as ‘n’ and ‘u’, respectively. These errors have now been corrected in both the PDF and HTML versions of the Article.Pengju WangXiaozhu LiJiwei WangDongling GaoYuenan LiHaoze LiYongchao ChuZhongxian ZhangHongtao LiuGuozhong JiangZhenguo ChengShengdian WangJianzeng DongBaisui FengLouisa S ChardNicholas R LemoineYaohe WangNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S Chard Nicholas R Lemoine Yaohe Wang Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
description	The originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as ‘n’ and ‘u’, respectively. These errors have now been corrected in both the PDF and HTML versions of the Article.
format	article
author	Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S Chard Nicholas R Lemoine Yaohe Wang
author_facet	Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S Chard Nicholas R Lemoine Yaohe Wang
author_sort	Pengju Wang
title	Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_short	Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_full	Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_fullStr	Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_full_unstemmed	Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_sort	author correction: re-designing interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/480ad26356494b4ba55bf572179933af
work_keys_str_mv	AT pengjuwang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT xiaozhuli authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT jiweiwang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT donglinggao authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yuenanli authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT haozeli authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yongchaochu authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT zhongxianzhang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT hongtaoliu authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT guozhongjiang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT zhenguocheng authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT shengdianwang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT jianzengdong authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT baisuifeng authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT louisaschard authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT nicholasrlemoine authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yaohewang authorcorrectionredesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent
_version_	1718380426734600192

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Ejemplares similares